Stefan Brinkmann - CEO @ Merz Therapeutics

Overview

CB Rank (Investor)

Stefan Brinkmann is the CEO of Merz Therapeutics. He attended University of Mannheim.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Vensica Medical	Merz Therapeutics	Yes	Corporate Round - Vensica Medical	obfuscated obfuscation

Number of Current Jobs

is the

CEO

Hub Name	CB Rank (Hub)
Hessen Companies (Top 10K)	5,664
Hessen Companies With More Than 10 Employees	8,084
Hessen Companies With More Than 50 Employees	12,581
Frankfurt Companies	9,607
Private Hessen Companies (Top 10K)	5,708
Private Frankfurt Companies	9,788
Germany Health Care Companies	7,628
Hessen Investors	27,504
Hessen Companies With Fewer Than 1000 Employees	6,542
Hessen Companies With More Than 100 Employees	15,236

studied at

There is no recent news or activity for this profile.